There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Prothena (PRTA – Research Report), RAPT Therapeutics (RAPT – Research Report) and Galera Therapeutics (GRTX – Research Report) with bullish sentiments.
Prothena (PRTA)
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Prothena today and set a price target of $75.00. The company’s shares closed last Monday at $61.55, close to its 52-week high of $66.47.
According to TipRanks.com, Fein is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Prothena has an analyst consensus of Strong Buy, with a price target consensus of $84.25, representing a 42.8% upside. In a report issued on December 5, Bank of America Securities also maintained a Buy rating on the stock with a $80.00 price target.
See the top stocks recommended by analysts >>
RAPT Therapeutics (RAPT)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on RAPT Therapeutics today and set a price target of $50.00. The company’s shares closed last Monday at $17.48.
According to TipRanks.com, Selvaraju is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for RAPT Therapeutics with a $41.20 average price target, a 141.5% upside from current levels. In a report issued on December 1, Goldman Sachs also initiated coverage with a Buy rating on the stock with a $27.00 price target.
Galera Therapeutics (GRTX)
In a report released today, Boobalan Pachaiyappan from H.C. Wainwright reiterated a Buy rating on Galera Therapeutics, with a price target of $10.00. The company’s shares closed last Monday at $1.74, close to its 52-week low of $1.12.
According to TipRanks.com, Pachaiyappan is ranked #5153 out of 8175 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Galera Therapeutics with a $10.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PRTA:
